Dinesh Nagi

2.5k total citations
63 papers, 1.4k citations indexed

About

Dinesh Nagi is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Genetics. According to data from OpenAlex, Dinesh Nagi has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Epidemiology and 14 papers in Genetics. Recurrent topics in Dinesh Nagi's work include Diabetes Management and Research (17 papers), Diabetes and associated disorders (14 papers) and Diabetes Treatment and Management (12 papers). Dinesh Nagi is often cited by papers focused on Diabetes Management and Research (17 papers), Diabetes and associated disorders (14 papers) and Diabetes Treatment and Management (12 papers). Dinesh Nagi collaborates with scholars based in United Kingdom, United States and Tanzania. Dinesh Nagi's co-authors include John Yudkin, William C. Knowler, Rosemary Temple, A Schneider, C. N. Hales, Peter H. Bennett, Vidya Mohamed‐Ali, David J. Pettitt, Peter J. Grant and Sobha Sivaprasad and has published in prestigious journals such as PLoS ONE, Diabetes Care and Diabetes.

In The Last Decade

Dinesh Nagi

61 papers receiving 1.4k citations

Peers

Countries citing papers authored by Dinesh Nagi

Since Specialization

Citations

This map shows the geographic impact of Dinesh Nagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dinesh Nagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dinesh Nagi more than expected).

Fields of papers citing papers by Dinesh Nagi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dinesh Nagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dinesh Nagi. The network helps show where Dinesh Nagi may publish in the future.

Co-authorship network of co-authors of Dinesh Nagi

This figure shows the co-authorship network connecting the top 25 collaborators of Dinesh Nagi. A scholar is included among the top collaborators of Dinesh Nagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dinesh Nagi. Dinesh Nagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID ‐19 2023 ·Diabetes Obesity and Metabolism ·Benjamin C. T. Field, Yue Ruan, (unknown), Jim Davies, Robert E. J. Ryder, Rajiv Gandhi, (unknown), Dinesh Nagi, Dipesh Patel, Punith Kempegowda, Sarah H. Wild, Emma G. Wilmot, Kamlesh Khunti, Rustam Rea, Parth Narendran, (unknown)	1
2	Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium–glucose cotransporter inhibitors with insulin for treatment of type 1 diabetes (Updated October 2020) 2020 ·Diabetic Medicine ·Umesh Dashora, Dipesh Patel, Robert Gregory, Peter Winocour, Ketan Dhatariya, (unknown), Andrew Macklin, Gerry Rayman, Dinesh Nagi	6
3	Remission of type 2 diabetes: a position statement from the Association of British Clinical Diabetologists (ABCD) and the Primary Care Diabetes Society (PCDS) 2019 ·British Journal of Diabetes ·Dinesh Nagi, Clare Hambling, Roy Taylor	61
4	Supported self-management for adults with type 2 diabetes and a learning disability (OK-Diabetes): study protocol for a randomised controlled feasibility trial 2015 ·Trials ·Rebecca Walwyn, Amy M. Russell, Louise Bryant, Amanda Farrin, Alexandra Wright‐Hughes, Liz Graham, Claire Hulme, John O’Dwyer, Gary Latchford, (unknown), Dinesh Nagi, Ramzi Ajjan, Allan House	19
5	Ethnic Variation in the Prevalence of Visual Impairment in People Attending Diabetic Retinopathy Screening in the United Kingdom (DRIVE UK) 2012 ·PLoS ONE ·Sobha Sivaprasad, Bhaskar Gupta, Martin Gulliford, Hiten Dodhia, Samantha Mann, Dinesh Nagi, Jennifer Evans	38
6	Ethnic Variations in the Prevalence of Diabetic Retinopathy in People with Diabetes Attending Screening in the United Kingdom (DRIVE UK) 2012 ·PLoS ONE ·Sobha Sivaprasad, Bhaskar Gupta, Martin Gulliford, Hiten Dodhia, Moin Mohamed, Dinesh Nagi, Jennifer Evans	109
7	A case of hypogonadotrophic hypogonadism due a pituitary stalk tuberculoma 2010 ·(unknown), (unknown), Dinesh Nagi	0
8	ABCD position statement on the management of hypogonadal males with type 2 diabetes 2010 ·Practical Diabetes International ·Ketan Dhatariya, Dinesh Nagi, T. Hugh Jones	5
9	A national survey of the current state of screening services for diabetic retinopathy: ABCD–Diabetes UK survey of specialist diabetes services 2006 2009 ·Diabetic Medicine ·Dinesh Nagi, (unknown), Chris Walton, Peter Winocour, Bridget Turner, Rhys Williams, J. James, Richard I. G. Holt	13
10	Diabetes specialist nurses and role evolvement: a survey by Diabetes UK and ABCD of specialist diabetes services 2007 2009 ·Diabetic Medicine ·J. James, (unknown), Peter Winocour, Chris Walton, Dinesh Nagi, Bridget Turner, Rhys Williams, Richard I. G. Holt	36
11	The use of basal insulin (NPH) compared with pre‐mixed biphasic insulin in patients with type 2 diabetes mellitus 2007 ·Practical Diabetes International ·(unknown), (unknown), Dinesh Nagi	0
12	Addisonian crisis in a patient with a progressive polyneuropathy 2003 ·(unknown), A. S. Najim Al-Din, N. Spencer, (unknown), Claire White, Dinesh Nagi, (unknown)	1
13	Randomized clinical trial of lifestyle interventions in Pima Indians: a pilot study 1998 ·Diabetic Medicine ·K.M. Venkat Narayan, Mary A. Hoskin, (unknown), Andrea M. Kriska, Robert L. Hanson, David J. Pettitt, Dinesh Nagi, Peter H. Bennett, William C. Knowler	98
14	Angiotensin-1—converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians 1998 ·Metabolism ·Dinesh Nagi, Carole A. Foy, Vidya Mohamed‐Ali, John Yudkin, Peter J. Grant, William C. Knowler	44
15	Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome 1996 ·Diabetologia ·L. J. McCormack, Dinesh Nagi, Max H. Stickland, Michael Mansfield, Vidya Mohamed‐Ali, John Yudkin, William C. Knowler, Peter J. Grant	30
16	Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians 1996 ·Metabolism ·Dinesh Nagi, Russell P. Tracy, Richard E. Pratley	23
17	Early and late insulin response as predictors of NIDDM in Pima Indians with impaired glucose tolerance 1995 ·Diabetologia ·Dinesh Nagi, W C Knowler, P. H. Bennett, Marie‐Aline Charles, (unknown), Robert L. Hanson, David R. McCance, (unknown)	4
18	Angiotensin Converting Enzyme (ACE) Insertion/Deletion (I/D) Polymorphism, and Diabetic Retinopathy in Subjects with IDDM and NIDDM 1995 ·Diabetic Medicine ·Dinesh Nagi, Michael Mansfield, Max H. Stickland, Peter J. Grant	31
19	Higher Levels of Microproteinuria in Asian Compared with European Patients with Diabetes Mellitus and Their Relationship to Dietary Protein Intake and Diabetic Complications 1994 ·Diabetic Medicine ·H Tindall, P. Martin, Dinesh Nagi, (unknown), Max H. Stickland, J A Davies	4
20	Gynaecomastia caused by a primary mediastinal seminoma 1994 ·Clinical Endocrinology ·Dinesh Nagi, William G. Jones, P E Belchetz	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact